SCHEMBL5375899

SCHEMBL5375899

Cc1ccc(C(=O)c2c(F)ccc(Cc3ccc(=O)[nH]n3)c2F)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 4/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ PARP1 P09874 2/20 0.36
▸ ALDH1A1 P00352 3/20 0.34
▸ CYP3A4 P08684 2/20 0.34
▸ KDM4E B2RXH2 2/20 0.33
▸ CYP1A2 P05177 2/20 0.33
▸ CYP2C9 P11712 2/20 0.33
▸ CYP2C19 P33261 2/20 0.33
▸ AKR1B1 P15121 2/20 0.33
▸ NPC1 O15118 2/20 0.33
▸ RAB9A P51151 2/20 0.33
▸ USP2 O75604 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ ALOX15 P16050 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8504764 0.77 ALDH1A1 (0.38) LMNAMEN1KMT2APARP1ALDH1A1
SCHEMBL7583728 0.72 CYP3A4 (0.40) KMT2AALDH1A1CYP3A4CYP2C9CYP2C19
SCHEMBL7582260 0.72 CYP3A4 (0.42) LMNACYP3A4AKR1B1POLBSMN1; SMN2
SCHEMBL8905800 0.71 AKR1B1 (0.54) LMNAMEN1KMT2AALDH1A1CYP3A4
SCHEMBL13633928 0.71 LMNA (0.37) LMNAMEN1KMT2APARP1ALDH1A1
SCHEMBL8906098 0.69 AKR1B1 (0.41) LMNAMEN1KMT2AALDH1A1AKR1B1
SCHEMBL5367001 0.69 MAPT (0.45) LMNAMEN1KMT2APARP1ALDH1A1
SCHEMBL8293709 0.69 PTGS2 (0.46) LMNAMEN1KMT2AALDH1A1CYP3A4
SCHEMBL7583539 0.69 CYP3A4 (0.42) LMNAMEN1KMT2ACYP3A4AKR1B1
SCHEMBL7584357 0.68 CYP3A4 (0.47) LMNAMEN1KMT2AALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7189718-B2 Non-nucleoside reverse transcriptase inhibitors ROCHE PALO ALTO LLC (US) 2007-03-13 — — US disclosed
US-7189718-B2 Non-nucleoside reverse transcriptase inhibitors ROCHE PALO ALTO LLC (US) 2007-03-13 — — US disclosed
US-7189718-B2 Non-nucleoside reverse transcriptase inhibitors ROCHE PALO ALTO LLC (US) 2007-03-13 — — US disclosed
EP-0810218-B1 6-Benzyl-2H-pyridazin-3-one derivatives,their preparation and their use as inhibitors of prostaglandin G/H synthase I and II (COX I and COX II) HOFFMANN LA ROCHE (CH) 2002-12-04 — — EP disclosed
EP-0810218-A1 6-Benzyl-2H-pyridazin-3-one derivatives,their preparation and their use as inhibitors of prostaglandin G/H synthase I and II (COX I and COX II) F. HOFFMANN-LA ROCHE AG (CH) 1997-12-03 — — EP disclosed
Send feedback